Sonlicromanol

DB16333InvestigationalSmall molecule

Sonlicromanol is under investigation in clinical trial NCT04165239 (The KHENERGYZE Study).

Mechanism: Pharmacologically active on Prostaglandin E synthase
Curator reviewed
Formula / weight: C₁₉H₂₈N₂O₃ · 332.444 g/mol (avg)
Also known as: (S)-6-Hydroxy-2,5,7,8-Tetramethyl-N-((R)-Piperidin-3-Yl)Chroman-2-Carboxamide
Code names: KH-176

Resolves to

Compound

Structure

InChIKeyLZYWLEPSQNXESC-KUHUBIRLSA-NSMILESCC1=C(O)C(C)=C2CC[C@](C)(OC2=C1C)C(=O)N[C@@H]1CCCNC1

Targets

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Sonlicromanol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.